Title | Type | SJR | H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | %Female (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
140 | Alimentary Pharmacology and Therapeutics Symposium Series | journal | 8 | 8 | 0 | 127 | 0 | 0 | 0.00 | 15.88 | 0.00 | ||
139 | American Journal of PharmacoGenomics | journal | 1.106 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
138 | Chemical Speciation and Bioavailability | journal | 0.544 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
137 | Expert Opinion on Drug Metabolism and Toxicology | journal | 100 | 51 | 0 | 5082 | 0 | 0 | 0.00 | 99.65 | 28.07 | ||
136 | Signal | journal | 1 | 22 | 0 | 327 | 0 | 0 | 0.00 | 14.86 | 0.00 | ||
135 | Particle and Fibre Toxicology | journal | 0.487 Q3 | 119 | 11 | 3 | 752 | 3 | 2 | 1.00 | 68.36 | 29.03 | |
134 | BMC Chemical Biology | journal | 0.261 Q4 | 21 | 3 | 4 | 102 | 4 | 4 | 1.33 | 34.00 | 33.33 | |
133 | Journal of Clinical Research | journal | 0.188 Q3 | 12 | 4 | 5 | 55 | 2 | 5 | 0.67 | 13.75 | 18.18 | |
132 | Reviews in Contemporary Pharmacotherapy | journal | 0.410 Q3 | 18 | 0 | 6 | 0 | 11 | 6 | 1.00 | 0.00 | 0.00 | |
131 | Advances in Antiviral Drug Design | book series | 0.347 Q2 | 12 | 0 | 7 | 0 | 6 | 7 | 0.86 | 0.00 | 0.00 | |
130 | Drug Discovery World | journal | 0.192 Q4 | 14 | 38 | 10 | 417 | 6 | 9 | 0.60 | 10.97 | 18.37 | |
129 | European Journal of Herbal Medicine | journal | 0.104 Q4 | 3 | 0 | 14 | 0 | 0 | 6 | 0.00 | 0.00 | 0.00 | |
128 | Journal of Immune Based Therapies and Vaccines | journal | 1.060 Q1 | 21 | 7 | 14 | 365 | 29 | 13 | 2.07 | 52.14 | 34.78 | |
127 | Journal of Negative Results in BioMedicine | journal | 0.219 Q3 | 25 | 12 | 14 | 427 | 11 | 12 | 0.73 | 35.58 | 34.00 | |
126 | Drug Design and Discovery | journal | 0.291 Q3 | 20 | 0 | 16 | 0 | 18 | 16 | 1.42 | 0.00 | 0.00 | |
125 | Expert Opinion on Drug Delivery | journal | 0.372 Q2 | 133 | 81 | 16 | 7108 | 25 | 14 | 1.56 | 87.75 | 29.17 | |
124 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.101 Q4 | 8 | 14 | 17 | 548 | 0 | 16 | 0.00 | 39.14 | 20.00 | |
123 | BMC Clinical Pharmacology | journal | 0.266 Q3 | 43 | 6 | 18 | 137 | 27 | 18 | 1.70 | 22.83 | 37.04 | |
122 | Journal of Nanobiotechnology | journal | 0.718 Q1 | 109 | 9 | 18 | 202 | 47 | 18 | 2.61 | 22.44 | 13.51 | |
121 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.324 Q3 | 25 | 0 | 19 | 0 | 37 | 19 | 0.00 | 0.00 | 0.00 | |
120 | American Journal of Drug Delivery | journal | 0.344 Q3 | 23 | 21 | 20 | 2033 | 16 | 20 | 0.80 | 96.81 | 34.09 | |
119 | Cytokines, Cellular and Molecular Therapy | journal | 0.505 Q3 | 28 | 0 | 21 | 0 | 32 | 21 | 0.00 | 0.00 | 0.00 | |
118 | Pharmacology Reviews and Communications | journal | 0.122 Q4 | 9 | 0 | 23 | 0 | 5 | 23 | 0.00 | 0.00 | 0.00 | |
117 | British Journal of Clinical Pharmacology, Supplement | journal | 0.706 Q1 | 33 | 0 | 27 | 0 | 110 | 25 | 3.56 | 0.00 | 0.00 | |
116 | Pharmaceutical Statistics | journal | 0.391 Q3 | 46 | 31 | 32 | 410 | 23 | 28 | 0.72 | 13.23 | 26.32 | |
115 | Journal of Applied Therapeutic Research | journal | 0.191 Q3 | 8 | 10 | 37 | 192 | 10 | 37 | 0.27 | 19.20 | 17.24 | |
114 | Comments on Toxicology | journal | 0.236 Q3 | 13 | 0 | 39 | 0 | 18 | 33 | 0.42 | 0.00 | 0.00 | |
113 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.009 Q1 | 99 | 12 | 40 | 1342 | 143 | 39 | 3.47 | 111.83 | 51.85 | |
112 | Environmental Pollutants and Bioavailability | journal | 39 | 16 | 41 | 501 | 43 | 40 | 1.29 | 31.31 | 31.82 | ||
111 | Paediatric and Perinatal Drug Therapy | journal | 0.275 Q3 | 20 | 14 | 42 | 327 | 33 | 35 | 0.72 | 23.36 | 48.15 | |
110 | Human Genomics | journal | 1.921 Q1 | 68 | 22 | 43 | 868 | 117 | 42 | 2.72 | 39.45 | 32.20 | |
109 | Journal of Drug Evaluation | journal | 0.136 Q4 | 5 | 0 | 45 | 0 | 4 | 19 | 0.09 | 0.00 | 0.00 | |
108 | Toxicological Reviews | journal | 0.737 Q2 | 49 | 29 | 46 | 1862 | 109 | 45 | 2.37 | 64.21 | 25.00 | |
107 | Mathematical Medicine and Biology | journal | 0.269 Q3 | 49 | 19 | 48 | 626 | 51 | 47 | 1.15 | 32.95 | 6.67 | |
106 | Critical Reviews in Toxicology | journal | 1.850 Q1 | 129 | 36 | 49 | 3985 | 298 | 47 | 5.45 | 110.69 | 32.84 | |
105 | Journal of Generic Medicines (discontinued) | journal | 0.192 Q3 | 16 | 47 | 54 | 444 | 11 | 48 | 0.20 | 9.45 | 20.59 | |
104 | Clinical Trials | journal | 0.621 Q2 | 74 | 71 | 60 | 1366 | 49 | 55 | 0.82 | 19.24 | 37.61 | |
103 | Drug Discovery Today: Technologies | journal | 0.335 Q3 | 62 | 55 | 62 | 1688 | 68 | 61 | 1.10 | 30.69 | 24.37 | |
102 | Drug Discovery Today: Disease Models | journal | 0.130 Q4 | 33 | 48 | 64 | 1909 | 8 | 64 | 0.13 | 39.77 | 32.48 | |
101 | Drug Discovery Today: Disease Mechanisms | journal | 0.156 Q4 | 28 | 81 | 65 | 3216 | 19 | 64 | 0.29 | 39.70 | 30.91 | |
100 | Pharmaceutical News | journal | 0.199 Q3 | 11 | 0 | 66 | 0 | 26 | 57 | 0.00 | 0.00 | 0.00 | |
99 | BMC Pharmacology | journal | 0.670 Q2 | 48 | 17 | 69 | 548 | 136 | 69 | 1.77 | 32.24 | 38.46 | |
98 | Cutaneous and Ocular Toxicology | journal | 0.172 Q4 | 37 | 24 | 71 | 677 | 27 | 70 | 0.49 | 28.21 | 36.84 | |
97 | Journal of Liposome Research | journal | 0.478 Q2 | 64 | 15 | 73 | 852 | 127 | 70 | 1.05 | 56.80 | 28.30 | |
96 | Drug Discovery Today: Therapeutic Strategies | journal | 0.201 Q3 | 31 | 55 | 74 | 2069 | 38 | 73 | 0.51 | 37.62 | 27.18 | |
95 | Pharmaceutical Medicine | journal | 0.108 Q4 | 25 | 43 | 81 | 829 | 8 | 59 | 0.08 | 19.28 | 30.65 | |
94 | Toxicology and Industrial Health | journal | 0.198 Q4 | 69 | 31 | 82 | 1016 | 62 | 81 | 0.26 | 32.77 | 30.50 | |
93 | Autonomic and Autacoid Pharmacology | journal | 0.301 Q3 | 24 | 22 | 83 | 782 | 73 | 82 | 0.75 | 35.55 | 31.25 | |
92 | Toxin Reviews | journal | 0.253 Q3 | 54 | 24 | 86 | 1359 | 64 | 77 | 0.74 | 56.63 | 21.43 | |
91 | Expert Opinion on Emerging Drugs | journal | 0.570 Q2 | 54 | 53 | 88 | 6214 | 194 | 86 | 2.83 | 117.25 | 20.18 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®